We are live on
!
Find out more
FG
Fairman Group Portfolio holdings
AUM
$127M
1-Year Est. Return
6.28%
This Fund
S&P 500
This Quarter
Est. Return
+2.4%
1 Year Est. Return
+6.28%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$125M
AUM Growth
+$995K
(+0.8%)
Cap. Flow
-$1.08M
Cap. Flow
% of AUM
-0.86%
Top 10 Holdings %
Top 10 Hldgs %
69.39%
Holding
355
New
81
Increased
61
Reduced
70
Closed
22
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$516K |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$424K |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$363K |
| 4 |
iMGP DBi Managed Futures Strategy ETF
DBMF
|
+$166K |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$151K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Veeva Systems
VEEV
|
+$1.15M |
| 2 |
Essent Group
ESNT
|
+$566K |
| 3 |
Microsoft
MSFT
|
+$360K |
| 4 |
Apple
AAPL
|
+$227K |
| 5 |
Accenture
ACN
|
+$215K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.14% |
| 2 | Financials | 9.97% |
| 3 | Healthcare | 3.31% |
| 4 | Consumer Discretionary | 1.2% |
| 5 | Industrials | 0.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Canadian National Railway
CNI
$77.2B
| $1.19K | ﹤0.01% |
12
-12
| -50% | -$1.15K |
|
302
GSK
GSK
$106B
| $989 | ﹤0.01% |
20
| – | – |
|
303
Virtus Investment Partners
VRTS
$1.1B
| $979 | ﹤0.01% |
6
| – | – |
|
304
Medtronic
MDT
$110B
| $975 | ﹤0.01% |
10
-10
| -50% | -$971 |
|
305
eBay
EBAY
$50.3B
| $958 | ﹤0.01% |
11
-11
| -50% | -$952 |
|
306
Unilever
UL
$136B
| $719 | ﹤0.01% |
11
-12
| -52% | -$806 |
|
307
Diageo
DEO
$53.5B
| $690 | ﹤0.01% |
8
-8
| -50% | -$737 |
|
|
OS
308
DELISTED
OneStream Inc
OS
| $625 | ﹤0.01% |
34
| – | – |
|
309
PPG Industries
PPG
$26.5B
| $615 | ﹤0.01% |
6
-6
| -50% | -$603 |
|
310
Tenet Healthcare
THC
$20.9B
| $596 | ﹤0.01% |
3
| – | – |
|
311
Baxter International
BAX
$14.1B
| $574 | ﹤0.01% |
30
| – | – |
|
312
Biogen
BIIB
$30.4B
| $528 | ﹤0.01% |
3
-3
| -50% | -$490 |
|
313
Commerce Bancshares
CBSH
$8.52B
| $471 | ﹤0.01% |
9
-10
| -53% | -$523 |
|
314
Molson Coors Class B
TAP
$8.1B
| $467 | ﹤0.01% |
10
-10
| -50% | -$461 |
|
315
Carrier Global
CARR
$53.1B
| $423 | ﹤0.01% |
8
-9
| -53% | -$500 |
|
316
CVS Health
CVS
$122B
| $397 | ﹤0.01% |
5
| – | – |
|
317
Otis Worldwide
OTIS
$28.3B
| $349 | ﹤0.01% |
4
-4
| -50% | -$358 |
|
318
Ambev
ABEV
$46.7B
| $308 | ﹤0.01% |
117
-117
| -50% | -$279 |
|
319
PENN Entertainment
PENN
$2.7B
| $221 | ﹤0.01% |
15
| – | – |
|
320
Mattel
MAT
$4.23B
| $198 | ﹤0.01% |
10
| – | – |
|
321
Fulton Financial
FULT
$4.66B
| $176 | ﹤0.01% |
9
| – | – |
|
322
Research Frontiers
REFR
$17M
| $164 | ﹤0.01% |
125
| – | – |
|
323
Immersion
IMMR
$249M
| $129 | ﹤0.01% |
19
| – | – |
|
324
Organon & Co
OGN
$3.56B
| $108 | ﹤0.01% |
15
| – | – |
|
325
Jackson Financial
JXN
$8.82B
| $107 | ﹤0.01% |
1
-1
| -50% | -$99 |
|
Similar funds
CF
S
MF
SAP
SIM
PIP
PC
IUC
Fairman Group's Q4 2025 Portfolio in Review
As of Q4 2025, Fairman Group held 355 positions worth $125M, up 0.8% from $124M the previous quarter. Its ten largest holdings account for 69% of the portfolio.
Fairman Group's Q4 2025 filing shows 81 new, 61 increased, 70 reduced and 22 closed positions. Its largest new stake was iShares S&P 500 Growth ETF: 3,466 shares worth $427K. The largest sale was Veeva Systems, an estimated $1.15M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Fairman Group's largest Q4 2025 buy was iShares S&P 500 Growth ETF: 3,466 shares worth $427K.
- Fairman Group added most to Vanguard FTSE Developed Markets ETF in Q4 2025, an estimated $516K increase.
- Fairman Group's biggest Q4 2025 reduction was Veeva Systems, cutting an estimated $1.15M.
- Fairman Group fully exited Vanguard Short-Term Inflation-Protected Securities Index Fund in Q4 2025, selling an estimated $116K.
- Fairman Group's ten largest holdings make up 69% of its $125M portfolio in Q4 2025.
- Fairman Group opened 81 new positions and closed 22 in Q4 2025.
- Fairman Group's portfolio value rose 0.8% quarter-over-quarter to $125M.
Based on Fairman Group's 13F filing for Q4 2025, filed 13 Feb 2026.